Bitter gourd, Momordica charantia L. (Cucurbitaceae) is a slender-stemmed tendril climber and is wildly cultivated as a vegetable crop in tropical and subtropical areas, including Asia, East Africa, and South America. Tissues of this plant have extensively been used in the treatment of diabetes and diseases of liver. Several pharmacological and phytochemical studies have revealed that the extracts or constituents of tissues of M. charantia possess anti-diabetic and anti-inflammatory activities.
Bitter gourd, Momordica charantia L. (Cucurbitaceae) is a slender-stemmed tendril climber and is wildly cultivated as a vegetable crop in tropical and subtropical areas, including Asia, East Africa, and South America. Tissues of this plant have extensively been used in the treatment of diabetes and diseases of liver. Several pharmacological and phytochemical studies have revealed that the extracts or constituents of tissues of M. charantia possess anti-diabetic and anti-inflammatory activities. [1] [2] [3] In addition, more than sixty cucurbitanetype triterpenoids have been isolated from the fruits, [3] [4] [5] [6] [7] [8] [9] [10] seeds, 11, 12) roots, 13) leaves and vines 14, 15) of M. charantia. As part of our program aimed at the discovery of the cucurbitane-type triterpenes from M. charantia originated in Taiwan, we reported the isolation and structural elucidation of fourteen cucurbitane-type triterpenoids from the MeOH extract of the stems of this plant. 16, 17) In our continuing investigation on M. charantia, we further purified four novel octanorcucurbitane triterpenes, 20,21,22,23,24,25,26,27-octanorcucurbit-5-ene-3,7,17-trione (1), 20,21,22,23,24,25,26,27-octanorcucurbit-5-ene-3,7,16-trione (2) , 5b,19-epoxy-20,21,22,23,24, 25,26,27-octanorcucurbit-6-ene-3,17-dione (3), and (19R)-5b ,19-epoxy-19-methoxy-20,21,22,23,24,25,26,27-octanorcucurbit-6-ene-3,17-dione (4), along with one known octanorcucurbitane triterpene, kuguacin M (5), 15) from the same part of the plant. This manuscript deals with the isolation and structural elucidation of the octanorcucurbitacins 1-5 and the protective effects on tert-butyl hydroperoxide (t-BHP)-induced hepatotoxicity and cytotoxic activities against human hepatoma HepG2 cells of octanorcucurbitacins 1-3 and 5 ( Fig. 1) .
Results and Discussion
Compound 1 was obtained as a white amorphous powder. Its high resolution electron impact mass spectrum (HR-EI-MS) gave a molecular ion at m/z 342.2192, corresponding to the molecular formula, C 22 H 30 O 3 , which indicated eight degrees of unsaturation. A significant UV absorption maximum at 248 nm suggested the presence of an a,b-unsaturated ketone. The IR spectrum showed absorption bands at 1654 cm Ϫ1 due to a conjugated ketone unit and 3050, 1654 and 890 cm Ϫ1 due to a conjugated double bond. In addition, the IR absorption bands at 1713 and 1742 cm Ϫ1 indicated two isolated ketone moieties located at six-membered and fivemembered rings, respectively. C-NMR data with those of the known compound, (23E)-25-hydroxycucurbita-5,23-diene-3,7-dione, 16) indicated that both compounds exhibited identical structure in rings A-C and the NMR signals of side chain (C20-27) were absent in 1. C-NMR spectrum of 4, and were resolved by DEPT experiments as four methyl, seven methylene, two methine, four quaternary, one hemiacetal methine, three ketone carbonyl, and one oxygenated quaternary, one methoxy carbons. The These cucurbitane-type triterpenes, except for 4, were evaluated for their cytotoxic activity against human hepatoma HepG2 cells with fluorouracil (5-FU) as a positive control (IC 50 ϭ1.6 mM).
18) Forty-eight hours after culture, they did not show significant growth inhibitory activity against the HepG2 cell line at a dose of 100 mM. The protective activities of compounds 1-3 and 5 on HepG2 cells injured by t-BHP was tested as reported previously.
19) The pretreatment of compounds 1 and 3 on HepG2 cells inhibited t-BHP-induced cytotoxicity. Compound 1 at a dose of 10 and 100 mM protected the t-BHP-induced cytotoxicity of HepG2 to 11.2% and 14.4% of control group, respectively. Meanwhile, compound 3 at a dose of 1 and 10 mM protected the t-BHP-induced cytotoxicity of HepG2 to 58.2% and 42.7% of control group, respectively (Fig. 4) . The protective effect of com- Fig. 4 . Cytoprotective Effect of 1 and 3 on t-BHP-Toxicified HepG2 Cells pound 3 was stronger than that of silybin, a commercial agent, which protected the t-BHP-induced cytotoxicity of HepG2 to 37.5% of control group at a dose of 10 mM (Fig. 4) .
Experimental
Optical rotations were measured by using a JASCO DIP-180 digital spectropolarimeter. UV spectra were measured in MeOH using a Shimadzu UV-1601PC spectrophotometer. IR spectra were recorded on a Nicolet 510P FT-IR spectrometer. NMR spectra were obtained in CDCl 3 at a constant temperature controlled and adjusted to around 300 K on a Varian Mercury plus 400 NMR spectrometer, and the residual proton resonance (CHCl 3 ) of CDCl 3 was used as internal shift reference. The 2D NMR spectra were recorded by using standard pulse sequences. EI-MS and HR-EI-MS were recorded on Finnigan TSQ-700 and JEOL SX-102A mass spectrometers, respectively. TLC was performed by using Si gel 60 F 254 plates (Merck). Column chromatography was performed on Si gel (230-400 mesh ASTM, Merck). HPLC was performed by using a Lichrosorb Si gel 60 (5 mm) column (250ϫ10 mm).
Plant Material The stems of M. charantia were collected in Pingtung County, Taiwan in July, 2003. The plant material was identified by Prof. Sheng-Zehn Yang, Curator of Herbarium, National Pingtung University of Science and Technology, where a voucher specimen (no. 2013) has been deposited.
Extraction and Isolation The sliced, air-dried stems (18 kg) of M. charantia were extracted with MeOH (3ϫ30 l) at room temperature (7 d each). The combined MeOH extract was evaporated under reduced pressure to afford a black residue, which was suspended in H 2 O (3 l), and then partitioned sequentially, using EtOAc and n-BuOH (3ϫ3 l) as solvent. The EtOAc fraction (386 g) was passed through a Si gel column (120ϫ10 cm), using a setpwise gradient mixture of hexane and EtOAc as eluent. Eleven fractions were collected as follows: 1 [5000 ml, hexane], 2 [4000 ml, hexane-EtOAc , and 11 (6000 ml, EtOAc). Fraction 7 was further chromatographed on a Si gel column (5ϫ45 cm), eluted with CH 2 Cl 2 -EtOAc (8 : 1 to 0 : 1) to obtain seven fractions (each about 600 ml), 7A-7G. Fr. 7D was subjected to column chromatography over Si gel eluted with hexane-CH 2 Cl 2 -EtOAc (3 : 3 : 1) and semipreparative HPLC eluted with hexane-EtOAc (7 : 3) to yield 3 (6 mg). Fraction 8 was further purified through a Si gel column (5ϫ45 cm), eluted with CH 2 Cl 2 -EtOAc (7 : 1 to 0 : 1) to obtain six fractions (each about 500 ml), 8A-8F. Si gel column chromatography of fr. 8C eluted with a CH 2 Cl 2 -EtOAc gradient (100 : 1 to 0 : 1) to yield 1 (5 mg). Fr. 8E was subjected to column chromatography over Si gel eluted with hexane-CH 2 Cl 2 -EtOAc (3 : 3 : 1) and semipreparative HPLC eluted with CH 2 Cl 2 -EtOAc (3 : 2) to yield 2 (10 mg), 4 (1 mg) and 5 (15 mg 
Cytotoxicity Assay
The cytotoxicity of compounds 1-3 and 5 was measured by using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] colorimetric method based on the described procedures with some modifications. 18) Briefly, a volume of HepG2 cells 100 ml at a density of 1ϫ10 5 cells/ml was incubated for 24 h in a 96-well flat-bottomed microplate. Test samples dissolved in DMSO were added to the medium and incubated for 48 h. Subsequently, the wells were incubated with the MTT (100 ml/well concentrated at 5 mg/ml) at 37°C for 4 h. After removing the supernatant, 200 ml of DMSO was added to redissolve the formazan crystals. The absorbance of the resulting formazan was measured by an enzymelinked immunosorbent assay plate reader at 550 nm. The results were assayed in triplicate. The ratio of cell viability (%) was calculated by using the following formula: [(experimental absorbanceϪbackground absorbance)/ (control absorbanceϪbackground absorbance)]ϫ100. The IC 50 values of each compound were obtained from 50% inhibition of cell growth and were compared with that of the control.
Protective Effect on Cytotoxicity Induced by t-BHP in HepG2 Cells The protective effect of compounds 1-3 and 5 on HepG2 cells injured by t-BHP was measured using the MTT colorimetric assay based on the described procedures with some modifications. 19) Briefly, HepG2 cells were plated on a 96-well plate with 1ϫ10 4 cells per well. The cells were treated with different concentrations of test compounds. After preincubated for 2 h, the cultured media were changed to the media containing t-BHP (100 mM), incubated for 3 h and then rinsed with phosphate-buffered saline. Subsequently, the wells were incubated with the MTT (100 ml/well concentrated at 5 mg/ml) at 37°C for 4 h. After removing the supernatant, 200 ml of DMSO was added to redissolve the formazan crystals. Absorbance at 550 nm was measured to estimate survived cells. The significance of various treatments was determined by the Student's t-test. The results were expressed as meanϮS.E.M. Differences were considered significant if pϽ0.05.
